| Overview |
| bsm-62132r-rbitc-100ul |
| Bcl2 modifying factor Recombinant Antibody, RBITC Conjugated |
| WB, Flow-Cyt |
| Human, Mouse, Rat |
| Specifications |
| RBITC |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Bcl 2 modifying factor |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 90427 |
| Q96LC9 |
| Cytoplasm, Cell membrane |
| Bcl2 modifying factor; Bmf. |
| May play a role in apoptosis. Isoform 1 seems to be the main initiator. |
| Application Dilution |
| WB |
1:300-5000 |
| Flow-Cyt |
1ug/Test |
Powered by Bioz